JETRO Startup


Global Startup Acceleration Program (GSAP) Alumnis実写 版 ブラック ジャックnc.

CIC '22 Bio/Healthcare

Healthcare Biotech


実写 版 ブラック ジャックs a privately owned preclinical stage start-up biotech developing oligonucleotide aptamer-based pharmaceuticals and medical devices. Our mission is to provide novel therapies using DNA aptamer discovery platform, Xenoligo beneficial for patients. TAGCyx can create innovative aptamers with high affinity and specificity for target molecules using our proprietary technology, artificial nucleic acid base and mini-hairpin stabilization structure.

Profile

Year founded
22-Mar-07
Name of the representative
Chizuko Koseki / President & CEO
HQ location(City)
Tokyo
Total amount raised to date
JPY1,800,000(as of Dec.2022) (Unit:JPY thousand, USD mio)
Stage
Series C
Major investors/VCs
Partnership
CAGE Bio Inc., Otsuka Chemical Co., Ltd., SBI Pharmaceuticals Co., Ltd., Resonac corporation,GC Pharma corp. 
Major Clients
 

CEO/Team

A picture of CEO/Team

*The contents of this page are subject to change without prior notice. Please contact us for the latest information.